BAYRY – bayer ag s/adr (US:NASDAQ)

News

Cancer-linked pesticide in the spotlight after controversial order: 'Toxic by design' [FOX News]
Bayer Reports Results for the Investigational Targeted Radionuclide Therapy ²²5Ac-PSMA-Trillium in Advanced Metastatic Prostate Cancer
Trump angering MAHA with glyphosate order gives Democrats an opening [CNBC]
Bayer’s XOFIGO® (radium-223 dichloride) Plus Enzalutamide Demonstrates Significant Overall Survival Benefit in PEACE-3 Trial in Patients With Metastatic Castration-Resistant Prostate Cancer With Bone Metastases
Lawyers for US cancer sufferers challenge Bayer's $7.25bn Roundup settlement deal [Yahoo! Finance]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com